Higher aspirin dose may better prevent dangerous pregnancy condition
NCT ID NCT07041385
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test whether 150 mg of aspirin works better than 75 mg to prevent preeclampsia in pregnant women at high risk. About 340 women aged 18-30 with a single pregnancy will take aspirin nightly from early pregnancy. The main goal is to see which dose reduces the chance of developing preeclampsia.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
aspirin
What this could lead to
If it works, this could show that a higher dose of aspirin is better at preventing preeclampsia in high-risk pregnant women, potentially reducing serious complications.
What could go wrong
This is a relatively small, single-center trial that hasn't started yet. The difference between doses may be small, and results may not apply to all populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREECLAMPSIA (PE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shalamar Hospital
Lahore, Punjab Province, 54000, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact